Syneos Health, Inc.
Syneos Health, Inc. (SYNH) Stock Overview
Explore Syneos Health, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.5B
P/E Ratio
16.61
EPS (TTM)
$0.70
ROE
0.08%
SYNH Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Syneos Health, Inc. (SYNH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $16.99.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.61 and a market capitalization of 4.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.